(Total Views: 517)
Posted On: 02/24/2020 6:43:32 AM
Post# of 149272
Interesting, market cap was 195M in 2015, to 5B in 2019, when it was bought out for 6B. I assume the great response rate in the basket trial had something to do with that market cap increase.
Eli Lilly (NYSE:LLY) has completed its acquisition of 26,043,820 common shares of Loxo Oncology (NASDAQ:LOXO) at $235 per share for a total of ~$6.12B, representing an 84.6% stake. Lilly will acquire the remaining non-tendered shares through a second-step merger.
Eli Lilly (NYSE:LLY) has completed its acquisition of 26,043,820 common shares of Loxo Oncology (NASDAQ:LOXO) at $235 per share for a total of ~$6.12B, representing an 84.6% stake. Lilly will acquire the remaining non-tendered shares through a second-step merger.
(0)
(0)Scroll down for more posts ▼
